Sydney Jennings

The US FDA approved norgestrel as the first daily oral contraceptive to be available over the counter, without a prescription.

Your daily dose of clinical news you may have missed.

Children and adolescents who reported facing more racial discrimination had a higher BMI and waist circumference, according to new data.

Your daily dose of clinical news you may have missed.

Underestimation of weight status increased while overestimation decreased during the last 2 decades, according to results from a study of over 745 000 adolescents.

Your daily dose of clinical news you may have missed.

The importance of avoiding judgement, monitoring behavior, and cardiovascular risk prevention in primary care are discussed, here.

Your daily dose of clinical news you may have missed.

In a study of over 26 000 participants, statin use was associated with reduced risk for all-cause and CV mortality compared to placebo.

Your daily dose of clinical news you may have missed.

Results showed that the use of opioid analgesics did not confer any benefits for adults with acute low back pain or neck pain compared to placebo.

Your daily dose of clinical news you may have missed.

Early intervention is crucial to help prevent complications in patients with obesity and type 2 diabetes. Two experts explain more, here.

Vitamin D supplementation may reduce the incidence of major cardiovascular events in older adults, suggests new research.

Your daily dose of clinical news you may have missed.

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Your daily dose of clinical news you may have missed.

ADA 2023: Findings from a new study show that higher levels of glycemia in childhood are associated with future microvascular complications, such as nephropathy and retinopathy.

Your daily dose of clinical news you may have missed.

Listen to 2 obesity experts discuss the impact of the COVID-19 pandemic on obesity-related type 2 diabetes.

Your daily dose of clinical news you may have missed.

ADA 2023. Results from PIONEER PLUS trial showed oral semaglutide 25 mg and 50 mg were superior than 14 mg in reducing HbA1c and body weight in adults with T2D.

Your daily dose of clinical news you may have missed.

ADA 2023. Once-daily oral semaglutide 50 mg induced 15.1% weight loss in adults with overweight or obesity without type 2 diabetes vs placebo.

Your daily dose of clinical news you may have missed.

Early intervention is important to reduce the risk for complications for patients with obesity and type 2 diabetes. Two obesity experts explain more, here.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Listen to 2 obesity experts discuss and analyze the role of insulin resistance in type 2 diabetes and obesity.

Your daily dose of clinical news you may have missed.